Olive Oil, Ibuprofen May Have Synergistic Effects

This article originally appeared here.
Share this content:
Olive Oil, Ibuprofen May Have Synergistic Effects
Olive Oil, Ibuprofen May Have Synergistic Effects

TUESDAY, June 13, 2017 (HealthDay News) -- The combination of extra virgin olive oil (EVOO) and ibuprofen at a therapeutic dose is superior to the two compounds used separately, according to an experimental study published online June 7 in the International Journal of Rheumatic Diseases.

Walla'a A. Osman, from Cairo University, and colleagues examined the analgesic, anti-pyretic, and anti-inflammatory activities of EVOO at a dose of 8 mL/kg body weight compared with ibuprofen as an individual drug therapy and in combination with two different doses of ibuprofen (therapeutic dose, 100 mg/kg; low dose, 40 kg/mg). One hundred thirty-two adult healthy male Swiss albino mice were examined. The anti-pyretic effect was assessed using brewer's yeast-induced pyrexia, and two different models were used to examine anti-inflammatory activity.

The researchers found that in all the treated groups there was significant protection. Compared with the two compounds used separately, the combination of EVOO and ibuprofen at its therapeutic dose showed superiority.

"Using EVOO with the therapeutic dose of ibuprofen showed synergistic effect in controlling the cardinal signs of acute inflammation rather than using nonsteroidal anti-inflammatory drugs alone," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths